BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu H, Zhou Y, Li W, Zhang B, Zhang H, Zhao S, Zheng P, Wu H, Yang J. Tumor-derived mesenchymal-stem-cell-secreted IL-6 enhances resistance to cisplatin via the STAT3 pathway in breast cancer. Oncol Lett 2018;15:9142-50. [PMID: 29844821 DOI: 10.3892/ol.2018.8463] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Y, Wells A, Sylakowski K, Clark AM, Ma B. Adult Stem Cell Functioning in the Tumor Micro-Environment. Int J Mol Sci 2019;20:E2566. [PMID: 31130595 DOI: 10.3390/ijms20102566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
2 Ryan D, Paul BT, Koziol J, ElShamy WM. The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells. Breast Cancer Res 2019;21:53. [PMID: 31014367 DOI: 10.1186/s13058-019-1131-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
3 Zhang S, Wang Q, Li D, Huang B, Hou X, Wang D, Xiao Z, Meng H, Zhang Y, Dong L. Oncolytic Vaccinia Virus-Mediated Antitumor Effect and Cell Proliferation Were Promoted in PTC by Regulating circRNA_103598/miR-23a-3p/IL-6 Axis. Cancer Manag Res 2020;12:10389-96. [PMID: 33116893 DOI: 10.2147/CMAR.S273072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lv Q, Xia Q, Li A, Wang Z, Khawar MB. circRNA_101277 Influences Cisplatin Resistance of Colorectal Cancer Cells by Modulating the miR-370/IL-6 Axis. Genetics Research 2022;2022:1-7. [DOI: 10.1155/2022/4237327] [Reference Citation Analysis]
5 Cui X, Jing X, Yi Q, Xiang Z, Tian J, Tan B, Zhu J. IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling. Oncol Rep 2019;41:2148-58. [PMID: 30816520 DOI: 10.3892/or.2019.7007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zheng Q, Zhang M, Zhou F, Zhang L, Meng X. The Breast Cancer Stem Cells Traits and Drug Resistance. Front Pharmacol. 2020;11:599965. [PMID: 33584277 DOI: 10.3389/fphar.2020.599965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li W, Yang J, Zheng P, Li H, Zhao S. The Origins and Generation of Cancer-Associated Mesenchymal Stromal Cells: An Innovative Therapeutic Target for Solid Tumors. Front Oncol 2021;11:723707. [PMID: 34513701 DOI: 10.3389/fonc.2021.723707] [Reference Citation Analysis]
8 Fang X, Zhong G, Wang Y, Lin Z, Lin R, Yao T. Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer. Cell Death Dis 2020;11:531. [PMID: 32661236 DOI: 10.1038/s41419-020-2735-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ni Y, Zhou X, Yang J, Shi H, Li H, Zhao X, Ma X. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment. Front Cell Dev Biol 2021;9:637675. [PMID: 34095111 DOI: 10.3389/fcell.2021.637675] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Hayal TB, Kıratlı B, Şişli HB, Şahin F, Doğan A. Mesenchymal Stem Cells as Regulators of Carcinogenesis. In: Turksen K, editor. Cell Biology and Translational Medicine, Volume 5. Cham: Springer International Publishing; 2019. pp. 147-66. [DOI: 10.1007/5584_2018_311] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Chulpanova DS, Solovyeva VV, James V, Arkhipova SS, Gomzikova MO, Garanina EE, Akhmetzyanova ER, Tazetdinova LG, Khaiboullina SF, Rizvanov AA. Human Mesenchymal Stem Cells Overexpressing Interleukin 2 Can Suppress Proliferation of Neuroblastoma Cells in Co-Culture and Activate Mononuclear Cells In Vitro. Bioengineering (Basel) 2020;7:E59. [PMID: 32560387 DOI: 10.3390/bioengineering7020059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Qu Y, Dou B, Tan H, Feng Y, Wang N, Wang D. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment. Mol Cancer 2019;18:69. [PMID: 30927928 DOI: 10.1186/s12943-019-0992-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]